interleukin 17A

Bimzelx, a potential blockbuster for psoriasis, clears FDA approval after resolving manufacturing issues

UCB’s long-awaited FDA approval for its psoriasis therapy, Bimzelx (bimekizumab), has finally arrived, ending a journey marked by manufacturing setbacks. ...